Share on facebook
Share on twitter
Share on linkedin

April, 2017: BioAegis Therapeutics Presents to Investors at the MACRO Trends Conference in Antwerp, Belgium

BOSTON, MA and MORRISTOWN, NJ, (BIOAEGIS THERAPEUTICS) April 25, 2017 BioAegis Therapeutics Inc., a privately held biotechnology company commercializing plasma gelsolin (pGSN), presented at the MACRO Trends Conference in Antwerp, Belgium  Presenting for the company was Mr. Steven Cordovano Co-Founder and Vice President of Investor Relations.

Read the full press release here: MACROTRENDS Cfx 2017